Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides
- 1 September 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (9), 2323-2329
- https://doi.org/10.1002/eji.1830270929
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope MutationThe Journal of Experimental Medicine, 1997
- Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infectionProceedings of the National Academy of Sciences, 1997
- Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.The Journal of Experimental Medicine, 1994
- Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.The Journal of Experimental Medicine, 1993
- A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificityJournal of Immunological Methods, 1993
- Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionNature, 1991
- A quantitative assay of peptide‐dependent class I assemblyEuropean Journal of Immunology, 1991
- Retroviral Recombination and Reverse TranscriptionScience, 1990
- HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptidesNature, 1988
- The Accuracy of Reverse Transcriptase from HIV-1Science, 1988